Allergy Therapeutics plc is a commercial biotechnology company focused on the diagnosis and treatment of allergic disorders. It operates in Germany, Austria, the United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, including treatments for pollen-related allergies (grasses, weeds, and trees) and diagnostic products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous immunotherapy candidate for allergic rhinoconjunctivitis due to grass pollen, and VLP Peanut, a short-course peanut allergy vaccine. Founded in 1998, the company is headquartered in Worthing, United Kingdom.